Abstract
Whilst the use of medication to treat psychiatric problems is less common in children and adolescents than in adults, rates of prescription are increasing for these groups. Notwithstanding a significant increase in the number and quality of clinical trials of psychotropic medications in children and adolescents there are continuing concerns that increases in rates of prescribing still outstrip the evidence base. For example, the prescribing of antipsychotics for children 7-12 years of age in primary care within the UK almost tripled between 1992 and 2005, with the prescribing of 'atypical antipsychotics' increasing 60-fold from 1994 to 2005 (Rani et al., 2008).
| Original language | English |
|---|---|
| Title of host publication | Seminars in Clinical Psychopharmacology |
| Subtitle of host publication | Third Edition |
| Publisher | Cambridge University Press |
| Pages | 525-542 |
| Number of pages | 18 |
| ISBN (Electronic) | 9781911623465 |
| ISBN (Print) | 9781911623458 |
| Publication status | Published - 18 Jun 2020 |